TrialA Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Trial details
- Registry ID
- NCT06667453
- Phase
- Phase 2
Drug research
PGN-EDODM1
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1NCT06667453 | PEPG | Phase 2 | Recruiting | 2027-03Estimated |
| An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)NCT07220603 | PEPG | Phase 2 | Recruiting | 2029-01Estimated |
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
Trial details
- Registry ID
- NCT07220603
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |